F. John Mills, MD, PhD



I stepped down as Chairman of BioStorage Technologies, a company I co-founded in 2004, following its successful sale for $127 million to Brooks Automation in December 2015. I’ve had global responsibility for managing clinical research and clinical support services. I have an extensive knowledge of pharmaceutical development, and my expertise is in business and marketing.

Prior to founding BioStorage Technologies, I spent three years as Corporate SVP and President of Clinical Support Services for Covance, Inc. (NYSE: CVD), a leading contract research organization headquartered in Princeton, New Jersey. While there, I was responsible for a $300 million-per-year clinical services division that employed more than 2,000 staff members globally. This group included Covance’s central laboratory operations in the United States, Europe, Australia, Singapore and South Africa, as well as clinical trial packaging facilities in the United States and Europe. For six years prior, I was based in the United Kingdom as Corporate VP for Covance’s European Clinical Division where I oversaw operations in a dozen European countries. Prior to my career with Covance, I held senior positions in Asia and Europe with Janssen Pharmaceutica, a division of Johnson & Johnson, Inc.

I received my M.D. from Cambridge University and my Ph.D. in endocrinology from Surrey University in the United Kingdom. I hold diplomas in pharmaceutical medicine, aviation medicine and marketing and have authored more than 40 scientific papers as well as a textbook on aviation medicine.